CMXC Insider Trading Activity and SEC Form 4 Filings
CMXC insider trading summary
No open-market insider purchases or sales of Cell MedX Corp. (CMXC) have been reported on SEC Form 4 in the past 12 months.
Latest CMXC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 29, 2023 | Richard Jeffs | 10% Owner | Buy | $101K (14,372,285 @ $0.01) |
| Dec 29, 2023 | David Jeffs | Chief Executive Officer | Buy | $53K (7,500,000 @ $0.01) |
| Dec 29, 2023 | David Jeffs | Chief Executive Officer | Buy | $53K (7,500,000 @ $0.01) |
| Apr 6, 2022 | Bradley S Hargreaves | VP Technology & Operations | Sell | $2K (10,000 @ $0.15) |
| Feb 7, 2022 | Bradley S Hargreaves | VP Technology & Operations | Sell | $54 (300 @ $0.18) |
| Feb 7, 2022 | Bradley S Hargreaves | VP Technology & Operations | Sell | $54 (300 @ $0.18) |
| Feb 4, 2022 | Bradley S Hargreaves | VP Technology & Operations | Sell | $1K (7,000 @ $0.15) |
| Jan 5, 2022 | Bradley S Hargreaves | VP Technology & Operations | Sell | $1K (7,500 @ $0.15) |
| Dec 29, 2021 | Bradley S Hargreaves | VP Technology & Operations | Sell | $923 (5,000 @ $0.18) |
| Dec 20, 2021 | Bradley S Hargreaves | VP Technology & Operations | Sell | $91K (5,000 @ $18.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.